News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Kalkine Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Aspire Biopharma Holdings, Inc. announced its successful participation in CPHI Frankfurt, engaging in strategic discussions with global pharmaceutical companies regarding its sublingual high-dose aspirin. The company conducted numerous meetings with major industry players to explore technical collaboration and licensing opportunities for its lead product …
This article reports on the filing of a Form 8K by Aspire Biopharma Holdings Inc. for August 10. The filing indicates a significant event or change at the company, as per SEC regulations. The content is brief, primarily serving as an announcement of the …
Aspire Biopharma has completed its acquisition of specified subsidiaries and assets from FireFish, a move aimed at expanding its business. To facilitate the closing, an escrow agreement was established on August 6, 2026, making the acquisition automatic upon payment. Concurrently, Aspire Biopharma secured $3.0 …
Aspire Biopharma has completed its acquisition of Dura Driver Control Systems (DCS), a tier-one automotive supplier, for $30 million in cash. This acquisition is a strategic move to transform Aspire into a diversified, high-revenue enterprise, leveraging DCS's global manufacturing presence, extensive intellectual property, and …
Aspire Biopharma Holdings (NASDAQ: ASBP) has completed its $30 million acquisition of Dura Driver Control Systems (DCS), marking its entry into the automotive and mobility-control market. The deal makes DCS a wholly-owned subsidiary, expected to add significant revenue, earnings, and cash flow to Aspire's …
Aspire Biopharma Holdings, Inc. announced the launch of its BUZZ BOMB(TM) Convenience Store Pack, expanding its retail presence in the energy category. BUZZ BOMB(TM) is a dry powder caffeine product delivered in single-serving stick packs designed for sublingual use, offering a rapid caffeine boost …
Aspire Biopharma Holdings Inc (ASBP) is an early-stage biopharmaceutical company focused on novel drug delivery mechanisms for FDA-approved drugs, nutraceuticals, and supplements. The company's stock shows strong performance over various periods, including a 1477.10% increase over the last year, despite a high P/E of …
This article provides details on the institutional confidence score for Aspire Biopharma Holdings Inc (ASBP), indicating a stable score of 3.00 as of July 28, 2026. It lists key institutional shareholders and their recent activity, showing significant percentage changes in holdings for some, such …
This article provides a valuation analysis of Aspire Biopharma Holdings Inc (ASBP), noting its current valuation score of 6.67 and its rank within the Biotechnology & Medical Research industry. It highlights the company's P/E ratio, mentioning that other relevant financial data such as P/B, …
This article provides the quarterly and annual income statements for Aspire Biopharma Holdings Inc (ASBP), offering insights into its financial performance, including revenue, operating expenses, special income, and net income figures across various fiscal periods. It also includes an FAQ section explaining how to …
This article provides a detailed risk assessment for Aspire Biopharma Holdings Inc (ASBP), covering volatility metrics, financial health, and investment risk. It presents various data points such as Beta vs S&P 500, maximum drawdown, realized volatility, Sharpe Ratio, and daily return/loss figures over different …
This article provides historical data on dividends and stock splits for Aspire Biopharma Holdings Inc (ASBP). It indicates that ASBP has not distributed any dividends in the past five years but lists two recent merger-related stock splits. The company's current stock price and market …
This article provides financial information for Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) on TradingView, focusing on revenue breakdown. It highlights the company's financial overview, statements, statistics, dividends, earnings, and segment performance.
Aspire Biopharma Holdings Inc. (ASBP) shows strong fundamentals and high growth potential, though its valuation is considered fairly valued within the Biotechnology & Medical Research industry. Institutional ownership is very high, and the stock is expected to trend upwards in the medium term, having …
Aspire Biopharma (ASBP) showed improved liquidity and modest revenue growth in Q1 2026, driven by significant capital raises. Despite these positive developments, the company continues to report substantial operating losses and relies heavily on external financing. Its financial profile suggests a high-risk investment due …
(RTTNews) - Today's top biotech gainers include Wellgistics following its rebranding, Femasys, which recently resolved its Nasdaq compliance issue, Vor Bio with continued progress in its Telitacicept program, and Sol-Gel Technologies as investors look ahead to key SGT-610 Phase 3 data, among others. Read …
Aspire Biopharma's subsidiary, Buzz Bomb Caffeine Company, has signed 16-time X Games medalist Jarryd McNeil as a Global Brand Ambassador for its BUZZ BOMB™ single-serve caffeine powder line. McNeil will promote the brand across his tours, competitions, and social media, while BUZZ BOMB™ aims …
MLQ.ai reported on an 8-K filing by Aspire Biopharma Holdings, Inc., dated July 20, 2026. This filing is categorized under "Other events" and is accessible directly on SEC.gov. The platform MLQ.ai provides research, news, and data related to frontier tech and financial filings.
Aspire Biopharma (ASBP) has clarified the terms of its public warrants following two reverse stock splits. The exercise price for these warrants is now $13,800, and the conversion ratio has been adjusted to 1,200 warrants per share of common stock. These changes result from …
Aspire Biopharma Holdings, Inc.'s subsidiary Buzz Bomb Caffeine Company LC has announced a partnership with multi-time X Games medalist and freestyle motocross legend Jarryd McNeil. McNeil will serve as a global brand ambassador for the BUZZ BOMB™ caffeine product line, integrating the branding into …
Search by ticker symbol or company name and select a result to open its chart.